g(m3)-ganglioside has been researched along with Guillain-Barre-Syndrome* in 3 studies
3 other study(ies) available for g(m3)-ganglioside and Guillain-Barre-Syndrome
| Article | Year |
|---|---|
[Guillain-Barré syndrome with refractory optic neuropathy].
A 60-year-old woman with a 3-day history of ataxic gait, blurred vision, and upper extremity paresthesia was admitted to our hospital. She presented with severe visual disturbances (finger counting), ophthalmoplegia, neck weakness, and sensory ataxia. Serum anti-GQ1b antibody, anti-GM3 antibody, and anti-GD3 antibody were strongly positive, which might contribute to the pathogenesis. Since we suspected Guillain-Barré syndrome (GBS), intravenous immunoglobulin therapy (IVIg) and high-dose steroid therapy were administered; however, improvements in her visual acuity were minimal. Additional IVIg and high-dose steroid therapy resulted in limited visual acuity improvements. Therapeutic strategies for patients with GBS and refractory optic neuropathy remain controversial. Topics: Autoantibodies; Biomarkers; Female; G(M3) Ganglioside; Gangliosides; Guillain-Barre Syndrome; Humans; Immunoglobulins, Intravenous; Methylprednisolone; Middle Aged; Optic Nerve Diseases; Pulse Therapy, Drug | 2019 |
Pharyngeal-cervical-brachial variant of Guillain-Barré syndrome with predominant bulbar palsy and anti-GM3 IgG antibodies.
Topics: Brachial Plexus; Bulbar Palsy, Progressive; Cervical Cord; Female; G(M3) Ganglioside; Guillain-Barre Syndrome; Humans; Immunoglobulin G; Middle Aged; Oropharynx | 2018 |
Guillain-Barré syndrome complicated with hemolytic anemia in association with antiganglioside GM3 antibody.
Topics: Aged; Anemia, Hemolytic; Autoantibodies; G(M3) Ganglioside; Gangliosidoses; Guillain-Barre Syndrome; Humans; Male | 2001 |